Welch Allyn Vital Signs 300 Series
The technology used in the Welch Allyn Vital Signs 300 Series, to measure blood pressure, has failed in a clinical validation study, in a specific population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||Not recommended||This device failed clinical validation.|
|BIHS (UK and IRL)||NOT recommended for pregnancy||Published evidence|
Nzelu D, Yeung F, Couderq D, Shennan A, Kametas NA. An inaccurate automated device negatively impacts the diagnosis and treatment of gestational hypertension. Pregnancy Hypertens. 2017 Oct;10:28-33. Epub: 2017 May 3. doi: 10.1016/j.preghy.2017.05.001. PMID: 29143739.
ESH-IP:2010 - Fail Pregnancy (n=33)
Schoot TS, Weenk M, van de Belt TH, Engelen LJLPG, van Goor H, Bredie SJH. A New Cuffless Device for Measuring Blood Pressure: A Real-Life Validation Study. J Med Internet Res. 2016 May;18(5):e85. Epub: 2016 May 05. doi: 10.2196/jmir.5414. PMID: 27150527. Available from: PMC4873623.
The use of this device for the reference measurements, in contravention to the ESH-IP 2010 protocol requirements, means that this study can be considered only as a comparison with the Viatom Checkme Health Monitor. It cannot be considered as a validation study.